152 related articles for article (PubMed ID: 38200171)
1. Targeting the dermis for melasma maintenance treatment.
Han HJ; Kim JC; Park YJ; Kang HY
Sci Rep; 2024 Jan; 14(1):949. PubMed ID: 38200171
[TBL] [Abstract][Full Text] [Related]
2. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Using Noninsulated Microneedle Radiofrequency Alone Versus in Combination with Polynucleotides for the Treatment of Melasma: A Pilot Study.
Gulfan MCB; Wanitphakdeedecha R; Wongdama S; Jantanapornchai N; Yan C; Rakchart S
Dermatol Ther (Heidelb); 2022 Jun; 12(6):1325-1336. PubMed ID: 35538360
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of melasma involving low-fluence Q-switched Nd:YAG laser and fractional microneedling radiofrequency.
Kwon HH; Choi SC; Jung JY; Park GH
J Dermatolog Treat; 2019 Jun; 30(4):352-356. PubMed ID: 30160539
[No Abstract] [Full Text] [Related]
5. Clinical Efficacy of Topical Tranexamic Acid With Microneedling in Melasma.
Kaur A; Bhalla M; Pal Thami G; Sandhu J
Dermatol Surg; 2020 Nov; 46(11):e96-e101. PubMed ID: 32769524
[TBL] [Abstract][Full Text] [Related]
6. Study of efficacy of microneedling and mesoneedling in the treatment of epidermal melasma: A pilot trial.
Farshi S; Mansouri P
J Cosmet Dermatol; 2020 May; 19(5):1093-1098. PubMed ID: 32196865
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of microneedling with topical tranexamic acid for melasma treatment: A systematic review and meta-analysis.
Feng X; Su H; Xie J
J Cosmet Dermatol; 2024 Jan; 23(1):33-43. PubMed ID: 37584240
[TBL] [Abstract][Full Text] [Related]
8. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
9. Tranexamic Acid for Melasma Treatment: A Split-Face Study.
Ebrahim HM; Said Abdelshafy A; Khattab F; Gharib K
Dermatol Surg; 2020 Nov; 46(11):e102-e107. PubMed ID: 32701529
[TBL] [Abstract][Full Text] [Related]
10. Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment of melasma: a split-face comparative study.
Abd Elraouf IG; Obaid ZM; Fouda I
Arch Dermatol Res; 2023 Aug; 315(6):1763-1770. PubMed ID: 36856856
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the effects of skin microneedling as adjuvant therapy for facial melasma: a pilot study.
Lima EVA; Lima MMDA; Paixão MP; Miot HA
BMC Dermatol; 2017 Nov; 17(1):14. PubMed ID: 29183309
[TBL] [Abstract][Full Text] [Related]
12. A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma.
Bhattacharjee R; Hanumanthu V; Thakur V; Bishnoi A; Vinay K; Kumar A; Parsad D; Kumaran MS
Arch Dermatol Res; 2023 Aug; 315(6):1831-1836. PubMed ID: 36757440
[TBL] [Abstract][Full Text] [Related]
13. Combination of a 755-nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split-face, and controlled trial.
Manuskiatti W; Yan C; Gulfan MCB; Techapichetvanich T; Wanitphakdeedecha R
Lasers Surg Med; 2022 Dec; 54(10):1245-1250. PubMed ID: 36345697
[TBL] [Abstract][Full Text] [Related]
14. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the combination of Q-switched Nd:YAG laser and microneedling for melasma.
Karadağ Köse Ö; Borlu M
J Cosmet Dermatol; 2021 Mar; 20(3):769-775. PubMed ID: 32696614
[TBL] [Abstract][Full Text] [Related]
16. A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
Debasmita B; Raj C; Ishan A; Ipsita D
J Cosmet Dermatol; 2022 Jul; 21(7):2801-2807. PubMed ID: 34636493
[TBL] [Abstract][Full Text] [Related]
17. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
Basit A; Rahman A; Uddin R
J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
[TBL] [Abstract][Full Text] [Related]
18. Platelet-rich plasma is a useful therapeutic option in melasma.
Hofny ERM; Abdel-Motaleb AA; Ghazally A; Ahmed AM; Hussein MRA
J Dermatolog Treat; 2019 Jun; 30(4):396-401. PubMed ID: 30220226
[No Abstract] [Full Text] [Related]
19. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
Patil NK; Bubna AK
Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of tranexamic acid versus vitamin c after microneedling in treatment of melasma: Clinical and Dermoscopic study.
El Attar Y; Doghaim N; El Far N; El Hedody S; Hawwam SA
J Cosmet Dermatol; 2022 Jul; 21(7):2817-2825. PubMed ID: 34699671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
